tiprankstipranks
Trending News
More News >

Belluscura PLC Evaluates Impact of US Tariffs on Operations

Story Highlights
Belluscura PLC Evaluates Impact of US Tariffs on Operations

Don’t Miss TipRanks’ Half-Year Sale

Belluscura PLC ( (GB:BELL) ) has issued an announcement.

Belluscura PLC is assessing the impact of newly proposed US tariffs on imports, which significantly affect their Portable Oxygen Concentrators and related components manufactured in China. The company has withdrawn its market guidance for the year ending December 2025 and plans to release further information once the situation is fully evaluated.

More about Belluscura PLC

Belluscura PLC is a UK-based medical device company that specializes in developing oxygen enrichment technology for various industries and therapies.

YTD Price Performance: -86.49%

Average Trading Volume: 1,420,391

Technical Sentiment Signal: Strong Buy

Current Market Cap: £5.02M

For detailed information about BELL stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1